Cardiac
Stress Testing
Corinne Jackson, MD
August 7, 2014
Objectives
 Indications
 Limitations
 Guidelines
 Value of results
Introduction
 Chest pain: 6 million visits per year
 2/3 undergo cardiac eval
 15-20% ACS
 Remaining possible ACS
 Cost: $10-12 billion
Clinical Case
 50 y/o female with diabetes, HTN, smoker
 Nonspecific substernal chest pain
 Slight dyspnea, no diaphoresis or N/V
 ECG nonspecific t wave flattening x 2 30 min apart
 Normal cardiac markers
 What to do?
Another case
 45 y/o male with chest pain while working outside
 No PCP
 BP 180/95
Last one
 69 yo male with HTN, hyperchol, DM with onset of
CP after emotional phone call
 Stress test at outside hospital 4 months ago normal
 ECG unchanged
 Negative biomakers
Next steps
 History
 Typical or atypical
 Risk factors
 Traditional less important
 Risk level
 Low, Intermediate, High
 Which study to order
CAD Likelihood
 Nature of anginal symptoms
 Prior CAD
 Sex
 Age
 Traditional risk factors
Angina
 Deep
 Poorly localized
 Exertion / emotional stress
 Relief with nitro / rest
 Anginal equivalents
Weak stories
 Pleuritic
 Lower/middle abdominal pain
 Pain localized at fingertip
 Reproducible pain
 Very brief
 Radiation to lower extremities
Risk factors
 Weakly predictive in acute setting
 Family history
TIMI Risk Classification
 Age >65
 >3 risk factors
 Known CAD
 >2 anginal episodes in the past 24 hours
 ASA use within 7 days
 ST segment deviation of 0.05mV or more
 Elevated cardiac marker
ACC/AHA Guidelines
Current Guidelines
 AHA/ACC
 Low risk patients who are pain free
 No recurrent symptoms
 No ischemic ECG changes
 Normal serial markers over 6-8 hours
 Stress in observation unit or outpatient
Types of Stress Testing
 ECG exercise treadmill test
 Exercise Stress Echo
 Dobutamine Stress Echo
 Nuclear stress Test
Sensitivity and Specificity
 Sensitivity
 Percentage of patients with a disease who will have
abnormal test
 Specificity
 Percentage of patients without disease who will have
normal test results
Pretest Probability
 False-positives
 False-negatives
Stress
 Exercise
 Pharmacologic
 Dobutamine
 Adenosine
 Regadenoson (Lexiscan)
 Dipyridamole
Imaging Technique
 ECG
 Echo
 Nuclear Imaging
 Tc-99m sestamibi
 Tc-99m-tetrofosmin
 Thallium
Exercise ECG
 Sensitivity 68%
 Specificity 77%
Exercise
 Treadmill
 Bicycle
ETT Selection
 Low to intermediate risk patients
 Ability to exercise
 No significant baseline ECG changes
 HD stable
 No arrhythmia
 Negative cardiac markers
ETT Not useful
 WPW
 Paced
 > 1 mm ST segment depression
 Complete LBBB
 Dig effect
ETT Absolute Contraindications
 AMI
 High risk UA
 Uncontrolled dysrhythmias
 Severe AS
 Active endocarditis
 Symptomatic HF
 Acute PE/DVT
 Myo/pericarditis
 Acute aortic dissection
ETT Relative Contraindications
 Left main disease
 Moderate valvular stenosis
 Electrolyte abnormalities
 Recent stroke /TIA
 HTN >200/110
 High degree AV block
 Tachy/brady dysrhythmias
 HCOM
 Wellens syndrome
Limitations
 Severe PAD
 COPD
 Degenerative arthritis
 Amputation
 General debilitation
 Mental health/cognitive impairment
ETT Procedure
 Bruce
 Modified Bruce protocol
ETT End Points
 Symptom-limited
 Ischemia
 > 0.10mV horizontal ST depression or elevation
 Decreased blood pressure during exercise
 > 10mmHg systolic
ETT Results
 Positive
 > 0.10mV horizontal ST depression
 Negative
 No exercise-induced abnormalities at 85% MPHR
 Nondiagnostic
 <85% MPHR with no ECG evidence of ischemia
ETT Benefits
 Simplicity
 Lower cost
ETT drawbacks
 Sensitivity
 Pretest probability
 Women
 Young patients
Stress Echocardiogram
 Exercise or pharmacologic stress
 Combines ECG stress with imaging at rest and after
stress
 Sensitivity 80%
 Specificity 84%
Stress Echocardiography
 Images synched to QRS complex
 Normal: increased contractility
 Positive: regional wall motion abnormalities
Stress Echo Indications
 Inability to exercise
 Baseline ECG alterations
Dobutamine
 Chronotrope
 Increases HR
Dobutamine Contraindications
 Recent MI/UA
 Aortic stenosis
 Cardiomyopathy
 Atrial tachycardias with uncontrolled vent response
 Uncontrolled HTN
 Thoracic Aortic Aneurysm
 LBBB
Stress Echo Pros
 Noninvasive
 No radiation exposure
 Structural and functional data
 Possible alternative diagnosis
Stress Echo Limitations
 Operator dependent
 Reader dependent
 Cannot detect subendocardial ischemia
 Timing
 Increased cost
Nuclear Stress Test
 IV radioactive tracer
 Rest
 Stress – usually pharmacologic
 SPECT or PET
Coronary Vasodilators
 Dipyridamole
 Adenosine
 Regadenson
Adenosine/Dipyridamole
Contraindications
 Active bronchospasm
 Allergy
 >1 degree AVB
 SBP <90
 Caffeine/aminophylline
 COPD (relative)
 Sick sinus syndrome (relative)
Regadenoson Contraindications
 2 degree AVB
 Sinus node dysfunction
 Acute myocardial ischemia
Myocardial Perfusion Imaging
 Thallium 201
 Technetium 99m sestamibi
 Technetium 99m tetrofosmin
 SPECT
Nuclear stress test indications
 Inability to exercise
 Baseline ECG abnormalities
 Intermediate risk patients with TIMI score of 4
MPI benefits
 Improved sensitivity (89%) and specificity (75%)
 Widely available
 Compatible with exercise, dobutamine, and
vasodilators
MPI Drawbacks
 Radioisotope
 Radiation
 Cost
 Long protocol
 Reader dependent
Cardiac CTA
 High sensitivity
 Radiation exposure
 No information on myocardial perfusion
Recent Negative Stress Test
 Consider alternative diagnosis
 Repeat ETT limited value
 “Warranty period”
 Plaque rupture
Case conclusions
Clinical Case
 50 y/o female with diabetes, HTN, smoker
 Nonspecific substernal chest pain
 Slight dyspnea, no diaphoresis or N/V
 ECG nonspecific t wave flattening x 2 30 min apart
 Normal cardiac markers
 What to do?
Another case
 45 y/o male with chest pain while working outside
 No PCP
 BP 180/95
Last one
 69 yo male with HTN, hyperchol, DM with onset of
CP after emotional phone call
 Stress test at outside hospital 4 months ago normal
 Negative biomarkers
 ECG unchanged
Summary
 Indications for different stress test modalities
 Consider your pretest probability
 Familiarity with guidelines
 It’s all about the story

More Related Content

PPT
Exercise stress ecg. dmo
PPTX
IImplantable Cardioverter Defibrillators (ICDs) - Dr Prithvi puwar
PPTX
Pace makers
PPT
Basic technical concepts in cardiac pacing
PPT
TMT interpretation
PPTX
Introduction To Electrophysiology
PPTX
LEFT HEART CATHETERIZATION
PPT
No reflow and slow flow phenomenon during pci
Exercise stress ecg. dmo
IImplantable Cardioverter Defibrillators (ICDs) - Dr Prithvi puwar
Pace makers
Basic technical concepts in cardiac pacing
TMT interpretation
Introduction To Electrophysiology
LEFT HEART CATHETERIZATION
No reflow and slow flow phenomenon during pci

What's hot (20)

PPTX
Echo assessment of lv systolic function and swma
PPTX
Right heart catheters
PPTX
Basic pacing concepts
PPT
Stress echocardiography
PPTX
Stress echocardiography
PPSX
Right heart catheterization
PPTX
BMV balloons- FINAL.pptx
PPTX
PRINCIPLES AND PRACTICES OF RIGHT HEART CATHETERIZATION IN CHILDREN
PPTX
Stress echocardiography/Dobutamine stress echocardiography
PPTX
Basics of Pacemaker Dr Hafeesh Fazulu Pushpagiri
PPTX
Coronary artery perforation
PPTX
Understanding pacemakers
PPTX
PPTX
Fontan circulation
PPTX
Trans septal Puncture in Cardiology
PPTX
PPT
Pacemaker overview
PPT
Fontan procedure
Echo assessment of lv systolic function and swma
Right heart catheters
Basic pacing concepts
Stress echocardiography
Stress echocardiography
Right heart catheterization
BMV balloons- FINAL.pptx
PRINCIPLES AND PRACTICES OF RIGHT HEART CATHETERIZATION IN CHILDREN
Stress echocardiography/Dobutamine stress echocardiography
Basics of Pacemaker Dr Hafeesh Fazulu Pushpagiri
Coronary artery perforation
Understanding pacemakers
Fontan circulation
Trans septal Puncture in Cardiology
Pacemaker overview
Fontan procedure
Ad

Similar to Stress Test Lecture (20)

PPTX
Non Invasive testing of myocardial ischemia AA.pptx
PPTX
Stress testing and outpatient workup of chest pain 2019
PPTX
NUCLEAR CARDIOLOGY111111111111111nov.pptx
PDF
09. Ischaemia assessments - What, when and which one.pdf
PPTX
imaging in ACS by Sia.pptx acute coronary syndrome
PPTX
Stresstesting housestaffdidactic_10092014[1]
PPTX
Stress%20 testing housestaff%20didactic_10092014[1]
PPT
Stress testing 2013
PPT
Final acs
PDF
Ischemic Heart Disease - Stable Angina Pectoris.pdf
PPTX
invasivenoninvasiveprocedureshRDIAV.pptx
PPTX
non invasive and invasive cardiac monitoring.pptx
PPTX
Acute coronary syndrome
PPTX
Evaluation of chest pain in primary care
PDF
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
PPTX
Stress Echocardiography in detail .pptx
PPTX
Kempton im noon_confpres_2018
PPTX
Thallium-Spect Scan
PPTX
Chest pain differential diagnosis
PPTX
Chronic Coronary Syndrome CCS Sisay.pptx
Non Invasive testing of myocardial ischemia AA.pptx
Stress testing and outpatient workup of chest pain 2019
NUCLEAR CARDIOLOGY111111111111111nov.pptx
09. Ischaemia assessments - What, when and which one.pdf
imaging in ACS by Sia.pptx acute coronary syndrome
Stresstesting housestaffdidactic_10092014[1]
Stress%20 testing housestaff%20didactic_10092014[1]
Stress testing 2013
Final acs
Ischemic Heart Disease - Stable Angina Pectoris.pdf
invasivenoninvasiveprocedureshRDIAV.pptx
non invasive and invasive cardiac monitoring.pptx
Acute coronary syndrome
Evaluation of chest pain in primary care
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Stress Echocardiography in detail .pptx
Kempton im noon_confpres_2018
Thallium-Spect Scan
Chest pain differential diagnosis
Chronic Coronary Syndrome CCS Sisay.pptx
Ad

Recently uploaded (20)

PPTX
SAPIENT3.0 Medi-trivia Quiz (PRELIMS) | F.A.Q. 2025
PPTX
Power point presentation on Spectrophotometry and Atomic Absorption Spec.pptx
PPTX
Male Infertility , Male Reproductive Organs disease,
PPTX
Gastro intestinalphysiology for medical students.pptx
PPTX
PHARMACOLOGY I notes for nursing studentspptx
PPTX
Bronchial Asthma2025 GINA Guideline.pptx
PPTX
INFLAMMATORY BOWEL DISEASE(U,CERATIVE COLITIS AND CHROHN'S DISEASE)
PPTX
Phamacology Presentation (Anti cance drugs).pptx
PPTX
Communicating with the FDA During an Inspection -August 26, 2025 - GMP.pptx
PPTX
Surgical Clinical and Applied Anatomy of Face .pptx
PPTX
PHARMACOLOGY NOTES FOR NURSING STUDENTS (1).pptx
PPTX
short stature evaluation in a child pediatrics.
PPTX
Connective tissue disorder C1 lecture (1).pptx
PDF
The Most Impactful Women CEOs Shaping the Future of Healthcare.pdf
PPT
Medical Emergencies in Maxillofacial_Surgery.ppt
PPTX
ENT-DISORDERS ( ent for nursing ). (1).p
PDF
11 Antiepileptic Drugs.pdf file for pharmacy
PPTX
Ocular Drug Delivery Systems: Advances, Challenges, and Pharmaceutical Applic...
PPT
First Aid Training for construction and other
PPTX
CHAPTER NO 2 Environment & Health , Psychosocial.pptx
SAPIENT3.0 Medi-trivia Quiz (PRELIMS) | F.A.Q. 2025
Power point presentation on Spectrophotometry and Atomic Absorption Spec.pptx
Male Infertility , Male Reproductive Organs disease,
Gastro intestinalphysiology for medical students.pptx
PHARMACOLOGY I notes for nursing studentspptx
Bronchial Asthma2025 GINA Guideline.pptx
INFLAMMATORY BOWEL DISEASE(U,CERATIVE COLITIS AND CHROHN'S DISEASE)
Phamacology Presentation (Anti cance drugs).pptx
Communicating with the FDA During an Inspection -August 26, 2025 - GMP.pptx
Surgical Clinical and Applied Anatomy of Face .pptx
PHARMACOLOGY NOTES FOR NURSING STUDENTS (1).pptx
short stature evaluation in a child pediatrics.
Connective tissue disorder C1 lecture (1).pptx
The Most Impactful Women CEOs Shaping the Future of Healthcare.pdf
Medical Emergencies in Maxillofacial_Surgery.ppt
ENT-DISORDERS ( ent for nursing ). (1).p
11 Antiepileptic Drugs.pdf file for pharmacy
Ocular Drug Delivery Systems: Advances, Challenges, and Pharmaceutical Applic...
First Aid Training for construction and other
CHAPTER NO 2 Environment & Health , Psychosocial.pptx

Stress Test Lecture

Editor's Notes

  • #3: Guideline of ACC/AHA
  • #4: ACS diagnosed by positive ECG findings and/or positive cardiac marker Rate of d/c for patients with ACS is 4% (risk highest in women and those with atypical pain); also overreliance on past studies in a common reason for missed/delayed diagnosis
  • #5: On and off for a couple days – sharp – worse with movement; no radiation; lasted for 1 hour or two then goes away on own Good story or bad story? Risk factors? FH?
  • #6: Substernal pressure – feels funny left arm, sweaty, dyspneic, felt better when I rested Good story for CP? Does not chol, normal BP, +smoker Risk factors? What do want to do?
  • #7: Deep pain – felt better when I took that they gave me nitro Had some on and off pain Negative biomarkers
  • #9: Nature of symptoms, HPI important. Clinical gestalt – pretty good predictive value Age most important and outweighs all other risk factors male >55 Female >65
  • #10: Or in other words – what is a good story? Chest /arm/shoulder/epigastric discomfort Anginal equivalents – dyspnea, n/v, diaphoresis, unexplained fatigue
  • #11: Pts that did not read the text books But 1 in 20 pts diagnosed with mi can have atypical features
  • #12: Framingham Risk Factors (first degree relative, male sex, advanced age, hypertension, smoking, dm, hyperlipidemia and family history) But a/w worse outcomes family history – inc risk of 30 day events, even greater with siblings
  • #13: Thrombolysis in Myocardial Infarction Used in ACS/UA 2010 Candian medical association journal Diagnostic accuracy of the TIMI risk score in patients with chest pain in the emergency department: a meta-analysis10 prospective cohort studies (with a total of 17 265 patients) Of patients with a score of zero, 1.8% had a cardiac event within 30 days (sensitivity 97.2%, 95% CI 96.4–97.8; specificity 25.0%, 95% CI 24.3–25.7; positive likelihood ratio 1.30, 95% CI 1.28–1.31; negative likelihood ratio 0.11, 95% CI 0.09–0.15). Meta-regression analysis revealed a strong linear relation between TIMI risk score (p < 0.001) and the cumulative incidence of cardiac events. Out of every 1000 pt 20 will experience a cardiac event within 30 days
  • #14: Excluded from guidelines – low likelihood CAD Eval for other causes – esophageal spasm, gastritis, PUD, dissection, neuropsychiatric symptoms
  • #15: Prefer 24 hours but up to 72 hours; recommend ASA and possible nitrates No RCT to support this Controversy in low risk chest pain: dependent on finding CAD that is amenable to revascularization. Exceedingly low in low risk pts
  • #18: Likelihood signs and symptoms represent ACS from obstructive CAD (contingent on likelihood of having CAD) diagnostic test you must consider this – why it is not helpful in very low risk or very high risk Negative stress test result in pt with high pretest prob – inc likelihood of false negative Positive stress test in a pt with a low pretest prob – inc false positive (increased in women, esp. young women)
  • #21: Mean numbers Sensitivity ranging from 23-100% and specificities 17-100% Marked differences in characteristics of populations studies, differences in definition of presence and severity of disease Limited by gold standard of angiography – work up bias (pts selected for cath are more likely to have obstructive CAD (inflates sensitivity and deflates specificity)
  • #22: Exercise increases oxygen demand from working muscle – to meet demands -> inc CO by increasing stroke volume and HR Myocardial oxygen uptake increase during exercise (linear relationship with coronary blood flow) Pts with obstructive CAD cannot provide adequate coronary blood flow to the affected myocardium during exercise causing ischemia St depression during demand induced subendocardial ischemia doe not localize area of myocardium Bicycle – better for orthopedic or balance problems – sitting or supine used to increased myocardial oxygen demand
  • #23: Most likely adequate exercise if can walk .5 min on flat ground and up 1-2 flights of stairs
  • #26: Dysrythmias with uncontrolled rate Wellens syndrome: T wave abnormality in precordial lead (v2, v3 +/- V4): specific for obstructive LAD lesion; high risk for anterior wall MI and death Type 1: deeply symmetric t waves; type 2: biphasic T waves with terminal T wave inversion Stress testing may precipitate AMI
  • #28: Initial warm up period followed by progressive graded exercise and recovery period Bruce protocol – incline and speed of treadmill increased every 3 minutes thru seven stages Starts 1.7mph at 10% incline; 3 min 2.5mph and incline 12%, similar increases every 3 minutes Modified – treadmill horizontal with first few intervals increased slope only Bruce protocol developed for middle age men – may not be optimal for elderly, obese and deconditioned – the large increments in aerobic requirements of successive stages leads to premature termination Various protocols reduces large workload changes between stages Assumption 85% MPHR (220-age in men ; 210-age in women) to diagnose ischemia has been challenged – tailor to pt’s true maximum exercise capacity Quantifying has a MET (metabolic equivalent) – superior format Abnormal chronotropic response predictive of cardiac events and death – inability to reach age predicted maximum heart rate or use the chronotopic index which takes into account resting heart rate
  • #29: STE Moderate to severe angina, fatigue, dyspnea,pt asks to stop CNS symptoms
  • #32: 60-70% sensitivity (although some studies as low as *23) Women: baseline ECG alterations, labile ST segment changes, breast artifact, lower exercise capacity, and false positive - women tend to have ischemia from vascular dysfunction (coronary endothelial and/or microvascular dysfunction) in absence of CAD Young patients – low CAD risk and no drug use - concern re: low positive predicative value (those that test positive who actually have disease) - majority of positive results are false - consider cost versus low likelihood of detection - excluding metabolic syndrome/multiple risk factors
  • #33: Low risk patient with negative stress echo less than 1% AMI/cardiac death within 1 year
  • #34: Myocardial contractility normally increases with exercise Ischemia causes hypo kinesis, a kinesis, or dyskinesis
  • #36: Direct iontrope and chronotrope that Increases myocardial oxygen demand in a way similar to exercise
  • #37: LBBB – can cause artifactual perfusion defects
  • #38: Real time anatomic and physiologic info PE (right heart strain), valvular disease, cardiomyopathy, ventricular aneurysm, and pericardial disease
  • #39: Adjacent wall segments = false + and – Wall thickening dependent on imaging technique Timing= Transient wall abnormality as resolve quickly COPD / obesity can = poor images
  • #40: Tracer distributed to coronary circulation Uptake occurs in proportion to regional myocardial blood flow Can do rest with pain – immediate Single photon emmision computed tomography
  • #41: Induces maldistribution of coronary perfusion Increase blood flow and cause vasodilatation in normal coronaries with little to no increase in stenotic arteries
  • #42: Aminophylline – competitive inhibitor of adenosine and can decrease vasodilatory effects Caffeine can block effects – withhold for 24 hours
  • #44: Thallium 201 potassium analogue that relies on uptake by viable myocardium Technetium (lipophilic cation that relies on negatively charged mitochondrial membrane SPECT= single photon emission CT Taken up myocardium and distributed in proportion to tissue perfusion Con of radiation exposure
  • #46: Sensitivity 89% and specificity 75% Rest spect imaging – neg low incidence of cardiac event/death High incidence of cardiac event after abnormal scan
  • #47: Reader dependent – decreased detection of subendocardial perfusion defect; motion artifact; scatter from gut and biliary activity; attenuation artifact (breat/subdiaphragmatic) Asses relative perfusion – decreased sensitivity for left main and 3 vessel disease
  • #48: Absence of CAD makes ACS unlikely – presence of such does not imply pain was cardiac in origin
  • #49: Up to 40% may be panic attack / somatoform disorder Careful reexamination for undetected cardiac disease Recent negative stress test can be useful without too much emphasis; should not prevent eval in pt with concerning story or EKG finings Positive stress : inc likelihood of acute event Negative stress still has 6 mo incidence ACS of 14% (stress test occurs prior to plaque rupture) – unpredictable and occurs in previous nonobstructive lesions No studies on warranty period – output stress test = normal stress MPI – overall cardiac event rate of 0.6% per year (predictor of event – h/o CAD< increased age, diabetes) Study in 2010 retrospective chart rev 20% pt presented with neg stress within last 3 years had significant CAD; 47% of which stress test was performed within 6months and 23% was performed within one month Another study revealed that it did not affect disposition decisions Serial cath - luminal diameter in normal arteries decreased by <3% per year; minor irregularities progressed at 6% per year. BUT plaque rupture occurs at non-flow-limiting lesions so estimates not absolute indicator of ACS
  • #51: TIMI risk score is 1 for >3 risk factors ETT – negative sent home for f/u
  • #52: Susternal pressure – feels funny left arm, sweaty, dyspnic, felt better when I rested Good story for CP? Smoker Does not chol, normal BP, no family history Risk factors? Timi 0-1 What do want to do? Ett positive- admitted for further w/u - cath with stent
  • #53: Deep pain – felt better when they gave me nitro Had some on and off pain Negative biomarkers Timi risk score of 3 (age, risk factors, ASA use) Admitted to cardiology – cath – medical managment
  • #54: Treadmill- no significant baseline ecg changes, ability to exercise, low to intermediate risk Echo – obesity, large breast size Nuclear – ecg changes, inability to exercise Start the work up – finish it ???Stress testing is useful in low and intermediate prevalence; high prevalence – stress will not lead to inclusion or exclusion of CAD More useful in confirming CAD than excluding it